Works by Walenkamp, Annemiek M. E.

Results: 24

The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.

Published in:

Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae241

By:

Janssen, Jorien B E;
Brahm, Cyrillo G;
Driessen, Chantal M L;
Nuver, Janine;
Labots, Mariette;
Kouwenhoven, Mathilde C M;
Aliaga, Esther Sanchez;
Enting, Roelien H;
Groot, Jan Cees de;
Walenkamp, Annemiek M E;
Linde, Myra E van;
Verheul, Henk M W

Publication type:

Article

Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy.

Published in:

European Journal of Hybrid Imaging, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41824-022-00133-6

By:

Veenstra, Emile B.;
Brouwers, Adrienne H.;
de Groot, Derk Jan A.;
Hofland, Johannes;
Walenkamp, Annemiek M. E.;
Brabander, Tessa;
Zandee, Wouter T.;
Noordzij, Walter

Publication type:

Article

The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors.

Published in:

EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00829-z

By:

Stormezand, Gilles N.;
Schreuder, Romano S. B. H.;
Brouwers, Adrienne H.;
Slart, Riemer H. J. A.;
Elsinga, Philip H.;
Walenkamp, Annemiek M. E.;
Dierckx, R. A. J. O.;
Glaudemans, Andor W. J. M.;
Luurtsema, Gert

Publication type:

Article

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.

Published in:

Cancers, 2021, v. 13, n. 22, p. 5675, doi. 10.3390/cancers13225675

By:

Stelwagen, Johannes;
Meuleman, Andrea T.;
Lubberts, Sjoukje;
Steursma, Gerrie;
Kruyt, Lara M.;
Donkerbroek, Jan W.;
Meijer, Coby;
Walenkamp, Annemiek M. E.;
Lefrandt, Joop D.;
Rakers, Sandra E.;
Huitema, Rients B.;
de Jong, Marianne A. A.;
Wiegman, Erwin M.;
van den Bergh, Alfons C. M.;
de Jong, Igle J.;
van Rentergem, Joost A. Agelink;
Schagen, Sanne B.;
Nuver, Janine;
Gietema, Jourik A.

Publication type:

Article

Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy.

Published in:

2020

By:

Stelwagen, Johannes;
Lubberts, Sjoukje;
Steggink, Lars C.;
Steursma, Gerrie;
Kruyt, Lara M.;
Donkerbroek, Jan Willem;
van Roon, Arie M.;
van Gessel, Anne I.;
van de Zande, Saskia C.;
Meijer, Coby;
Gräfin zu Eulenburg, Christine H.;
Oosting, Sjoukje F.;
Nuver, Janine;
Walenkamp, Annemiek M. E.;
Jan de Jong, Igle;
Lefrandt, Joop D.;
Gietema, Jourik A.

Publication type:

journal article

Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial).

Published in:

2018

By:

Ormel, Harm L.;
van der Schoot, Gabriela G. F.;
Westerink, Nico-Derk L.;
Gietema, Jourik A.;
Walenkamp, Annemiek M. E.;
Sluiter, Wim J.

Publication type:

journal article

Web-based information and support for patients with a newly diagnosed neuroendocrine tumor: a feasibility study.

Published in:

2017

By:

Bouma, Grietje;
Hosson, Lotte;
Woerkom, Claudia;
Essen, Hennie;
Bock, Geertruida;
Admiraal, Jolien;
Reyners, Anna;
Walenkamp, Annemiek;
de Hosson, Lotte D;
van Woerkom, Claudia E;
van Essen, Hennie;
de Bock, Geertruida H;
Admiraal, Jolien M;
Reyners, Anna K L;
Walenkamp, Annemiek M E

Publication type:

journal article

Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers.

Published in:

Pathology & Oncology Research, 2020, v. 26, n. 3, p. 1539, doi. 10.1007/s12253-019-00734-w

By:

Peters, Marloes A. M.;
Meijer, Coby;
Fehrmann, Rudolf S. N.;
Walenkamp, Annemiek M. E.;
Kema, Ido P.;
de Vries, Elisabeth G. E.;
Hollema, Harry;
Oosting, Sjoukje F.

Publication type:

Article

Does the Capsule Component of the Cryptococcus neoformans Glucuronoxylomannan Impair Transendothelial Migration of Leukocytes in Patients with Cryptococcal Meningitis?

Published in:

Journal of Infectious Diseases, 1998, v. 178, n. 4, p. 1231

By:

Lipovsky, Myriam M.;
van Elden, Leontine J. R.;
Walenkamp, Annemiek M. E.;
Dankert, Jacob;
Hoepelman, Andy I. M.

Publication type:

Article

CXCR4 Ligands: The Next Big Hit?

Published in:

Journal of Nuclear Medicine, 2017, v. 58, p. 77S, doi. 10.2967/jnumed.116.186874

By:

Walenkamp, Annemiek M. E.;
Lapa, Constantin;
Herrmann, Ken;
Wester, Hans-Jürgen

Publication type:

Article

TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.

Published in:

Journal of Nuclear Medicine, 2015, v. 56, n. 9, p. 1310, doi. 10.2967/jnumed.115.154401

By:

den Hollander, Martha W.;
Bensch, Frederike;
Glaudemans, Andor W. J. M.;
Munnink, Thijs H. Oude;
Enting, Roelien H.;
den Dunnen, Wilfred F. A.;
Heesters, Mart A. A. M.;
Kruyt, Frank A. E.;
Lub-de Hooge, Marjolijn N.;
de Groot, Jan Cees;
Pearlberg, Joseph;
Gietema, Jourik A.;
de Vries, Elisabeth G. E.;
Walenkamp, Annemiek M. E.

Publication type:

Article

Everolimus Reduces 89Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.

Published in:

Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1087, doi. 10.2967/jnumed.113.129056

By:

van Asselt, Sophie J.;
Oosting, Sjoukje F.;
Brouwers, Adrienne H.;
Bongaerts, Alfons H. H.;
de Jong, Johan R.;
Lub-de Hooge, Marjolijn N.;
Oude Munnink, Thijs H.;
Fiebrich, Helle-Brit;
Sluiter, Wim J.;
Links, Thera R.;
Walenkamp, Annemiek M. E.;
de Vries, Elisabeth G. E.

Publication type:

Article

Placental Growth Factor (PIGF)-Specific Uptake in Tumor Microenvironment of 89Zr-Labeled PIGF Antibody RO5323441.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 6, p. 929, doi. 10.2967/jnumed.112.112086

By:

Munnink, Thijs H. Oude;
Tamas, Karin R.;
Lub-de Hooge, Marjolijn N.;
Vedelaar, Silke R.;
Timmer-Bosscha, Hetty;
Walenkamp, Annemiek M. E.;
Weidner, K. Michael;
Herting, Frank;
Tessier, Jean;
de Vries, Elisabeth G. E.

Publication type:

Article

PET with the 89Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models.

Published in:

Journal of Nuclear Medicine, 2011, v. 52, n. 12, p. 2001, doi. 10.2967/jnumed.111.092809

By:

Munnink, Thijs H. Oude;
Arjaans, Marlous E. A.;
Timmer-Bosscha, Hetty;
Schröder, Carolina P.;
Hesselink, Jan W.;
Vedelaar, Silke R.;
Walenkamp, Annemiek M. E.;
Reiss, Michael;
Gregory, Richard C.;
Lub-de Hooge, Marjolijn N.;
de Vries, Elisabeth G. E.

Publication type:

Article

False-positive findings on 6-[18F]fluor-l-3,4- dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors.

Published in:

European Journal of Endocrinology, 2018, v. 179, n. 2, p. 125, doi. 10.1530/EJE-18-0321

By:

Berends, Annika M. A.;
Kerstens, Michiel N.;
Bolt, Janne W.;
Links, Thera P.;
Korpershoek, Esther;
de Krijger, Ronald R.;
Walenkamp, Annemiek M. E.;
Noordzij, Walter;
van Etten, Boudewijn;
Kats-Ugurlu, Gursah;
Brouwers, Adrienne H.;
van der Horst-Schrivers, Anouk N. A.

Publication type:

Article

Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study.

Published in:

Journal of Neuro-Oncology, 2025, v. 173, n. 1, p. 147, doi. 10.1007/s11060-025-04973-7

By:

van der Weide, Hiska L.;
Buunk, Anne M.;
Siebenga, Femke F.;
Langendijk, Johannes A.;
Bannink-Gawryszuk, Agata;
Bosma, Ingeborg;
Enting, Roelien H.;
van der Hoorn, Anouk;
Jeltema, Hanne-Rinck;
Wagemakers, Michiel;
Groen, Rob J. M.;
Walenkamp-Hageman, Annemiek M. E.;
Nuver, Janine;
Kramer, Miranda C. A.;
Spikman, Jacoba M.

Publication type:

Article

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.

Published in:

Journal of Neuro-Oncology, 2019, v. 144, n. 1, p. 205, doi. 10.1007/s11060-019-03222-y

By:

Lassman, Andrew B.;
Aldape, Kenneth D.;
Ansell, Peter J.;
Bain, Earle;
Curran, Walter J.;
Eoli, Marica;
French, Pim J.;
Kinoshita, Manabu;
Looman, Jim;
Mehta, Minesh;
Muragaki, Yoshihiro;
Narita, Yoshitaka;
Ocampo, Christopher;
Roberts-Rapp, Lisa;
Song, Minghao;
Vogelbaum, Michael A.;
Walenkamp, Annemiek M. E.;
Wang, Tony J. C.;
Zhang, Peixin;
van den Bent, Martin J.

Publication type:

Article

Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 13, p. 2404, doi. 10.1007/s00259-018-4090-4

By:

den Hollander, Martha W.;
de Vries, Elisabeth G. E.;
Walenkamp, Annemiek M. E.;
Brahm, Cyrillo G.;
Verheul, Henk M. W.;
Enting, Roelien H.;
de Groot, Jan Cees;
Solouki, A. Millad;
den Dunnen, Wilfred F. A.;
Heesters, Mart A. A. M.;
Wagemakers, Michiel;
Pruim, Jan

Publication type:

Article

Neuroendocrine tumours and their microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1449, doi. 10.1007/s00262-020-02556-1

By:

de Hosson, Lotte D.;
Takkenkamp, Tim J.;
Kats-Ugurlu, Gursah;
Bouma, Grietje;
Bulthuis, Marian;
de Vries, Elisabeth G. E.;
van Faassen, Martijn;
Kema, Ido P.;
Walenkamp, Annemiek M. E.

Publication type:

Article

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.

Published in:

2020

By:

Qiu, Si-Qi;
van Rooijen, Johan;
Nienhuis, Hilde H.;
van der Vegt, Bert;
Timmer-Bosscha, Hetty;
van Leeuwen-Stok, Elise;
Walenkamp, Annemiek M. E.;
van Deurzen, Carolien H. M.;
de Bock, Geertruida H.;
de Vries, Elisabeth G. E.;
Schröder, Carolien P.

Publication type:

journal article

Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach.

Published in:

PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0115687

By:

Conroy, Siobhan;
Kruyt, Frank A. E.;
Joseph, Justin V.;
Balasubramaniyan, Veerakumar;
Bhat, Krishna P.;
Wagemakers, Michiel;
Enting, Roelien H.;
Walenkamp, Annemiek M. E.;
Dunnen, Wilfred F. A. den

Publication type:

Article

Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors.

Published in:

Clinical Chemistry, 2019, v. 65, n. 11, p. 1388, doi. 10.1373/clinchem.2019.305359

By:

van Faassen, Martijn;
Bouma, Grytsje;
de Hosson, Lotte D.;
Peters, Marloes A. M.;
Kats-Ugurlu, Gursah;
de Vries, Elisabeth G. E.;
Walenkamp, Annemiek M. E.;
Kema, Ido P.

Publication type:

Article

Response to Alwardat comments on our systematic review entitled: "Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review".

Published in:

2018

By:

Ormel, Harm L.;
Walenkamp, Annemiek M. E.

Publication type:

Letter

Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17467, doi. 10.1007/s00432-023-05469-5

By:

van der Schoot, Gabriela G. F.;
Ormel, Harm L.;
Westerink, Nico-Derk L.;
Wempe, Johan B.;
Lefrandt, Joop D.;
May, Anne M.;
Vrieling, Aline H.;
Meijer, Coby;
Gietema, Jourik A.;
Walenkamp, Annemiek M. E.

Publication type:

Article

Works by Walenkamp, Annemiek M. E.

The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.

Comparison of [<sup>18</sup>F]DOPA and [<sup>68</sup>Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy.

The effects of molar activity on [<sup>18</sup>F]FDOPA uptake in patients with neuroendocrine tumors.

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.

Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy.

Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial).

Web-based information and support for patients with a newly diagnosed neuroendocrine tumor: a feasibility study.

Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers.

Does the Capsule Component of the Cryptococcus neoformans Glucuronoxylomannan Impair Transendothelial Migration of Leukocytes in Patients with Cryptococcal Meningitis?

CXCR4 Ligands: The Next Big Hit?

TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET.

Everolimus Reduces <sup>89</sup>Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.

Placental Growth Factor (PIGF)-Specific Uptake in Tumor Microenvironment of <sup>89</sup>Zr-Labeled PIGF Antibody RO5323441.

PET with the <sup>89</sup>Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models.

False-positive findings on 6-[<sup>18</sup>F]fluor-l-3,4- dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors.

Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study.

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.

Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.

Neuroendocrine tumours and their microenvironment.

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.

Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach.

Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors.

Response to Alwardat comments on our systematic review entitled: "Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review".

Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis.